Kidneys and bladder

76 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Kidneys and bladder
Treatment and conditionWhere it standsTrials
10 GE Xenokidney for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
AMDC-USR (iltamiocel) for urinary incontinence, stressPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Apecotrep for glomerulosclerosis, focal segmentalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
ARBs in combination of SGLT2i for proteinuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arm 2A: TRACT/MONO mTOR for kidney failure, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Arm 2B: TRACT/MONO CNI for kidney failure, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atrasentan for proteinuriaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
AZD7760 for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Belantamab mafodotin for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bepirovirsen for renal insufficiencyPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bladder Transplantation for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Botulinum toxin type a for urinary bladder, overactivePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Botulinum toxin type a for urinary incontinencePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brivekimig for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brivekimig for nephrosis, lipoidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cagrilintide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ChoironeX GalKO Porcine Thymokidney for kidney failure, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cilastatin for acute kidney injuryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cilastatin sodium for acute kidney injuryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combined Kidney and Bladder Transplantation for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Concomitant Renal and Urinary Bladder Allograft Transplantation for bladder exstrophyPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Concomitant Renal and Urinary Bladder Allograft Transplantation for renal insufficiency, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Concomitant Renal and Urinary Bladder Allograft Transplantation for urinary bladder neck obstructionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Droxidopa for acute kidney injuryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elasomeran for renal insufficiency, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney + Kidney Transplantation with Standard Care for kidney failure, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Frexalimab for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Frexalimab for nephrosis, lipoidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
GGTA1 KO Thymokidney for kidney failure, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Heparin for cystitis, interstitialPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HRS-1780 tablets for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
IGT-303 for renal insufficiency, chronicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Intensified medical follow-up and glucose-lowering drugs for kidney diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Iptacopan for proteinuriaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
JADE101 for proteinuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lidocaine for cystitis, interstitialPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for albuminuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN + GALLIUM GA-68 GOZETOTIDE for renal insufficiencyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Melatonin for ureteral calculiPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MSCs for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MT1013 for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
NightWare for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Paxlovid for uremiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for glomerulosclerosis, focal segmentalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + SOTAGLIFLOZIN for albuminuriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for albuminuriaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rilzabrutinib for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rilzabrutinib for nephrosis, lipoidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Semaglutide + Cagrilintide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sodium zirconium cyclosilicate for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
solifenacin combined with gabapentin for urinary bladder, overactiveTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
standard care + rotigotine at 4 mg/24h for 24 months. for kidney diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Suzetrigine for urinary incontinence, stressTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tenofovir Alafenamide Citrate for renal insufficiencyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Testosterone for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ticagrelor for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for renal insufficiency, chronicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tolvaptan for polycystic kidney, autosomal recessivePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tozinameran for renal insufficiency, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
UKidney for kidney failure, chronicTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Upacicalcet for renal insufficiency, chronicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Virtual Weight Management Coaching + Semaglutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
VNX001 for cystitis, interstitialPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VX-407 for polycystic kidney, autosomal dominantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
YOLT-203 for kidney calculiPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zigakibart for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1